BioIVT, a provider of research models and services for drug development, has acquired Santa Clara, CA-based Optivia Biotechnology and its portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions. Financial details were not disclosed.   Transport proteins govern drug concentration in the blood and vital organs and effects are evaluated early in the lead candidate selection and optimization process in drug R&D programs...